This Month in Psychopharmacology

October is ADHD Awareness Month

Image
Image

October is ADHD Awareness Month. The mission of ADHD Awareness Month is to educate the public about ADHD by disseminating reliable information based on the evidence of science and peer-reviewed research. ADHD continues through adolescence and into adulthood, affecting approximately 5% of the child population worldwide and 2% to 4% of the adult population worldwide. Comorbid conditions are common and obscure ADHD diagnosis and make it difficult for patients to receive optimal treatment. Child and adult patients with ADHD have unique requirements for symptom management throughout the day and evening. Judicious medication choice entails detailed knowledge of therapeutic response and side effects associated with the available medications, as well as the particular needs of the patient, including any comorbid conditions and all-day symptom management.

ADHD Education and Resources

Image

Encore Presentation
Similar but Different: Exploring the Options for Treating ADHD
CME/CE Credit: 0.75  |  Expires: November 7, 2024

Image

Encore Presentation
Sunrise to Sunset: Shedding a Light on the Treatment of Pediatric ADHD
CME/CE Credit: 1.0  |  Expires: November 3, 2024

Image

Stahl's Essential Videos
Stahl’s Essential Psychopharmacology, Chapter 11b: Treatment of ADHD
CME/CE credits: 0.5   |   Expires: March 24, 2025

Image

Patient Education
ADHD Neurobiology Coloring Page
Fun and educational patient handouts!

Image

CNS Spectrums CME Article
A Clinician’s Guide for Navigating the World of ADHD Medications
CME/CE Credit: 1.0  |  Expires: December 18, 2023

Image

NEI Saturday Morning Live!
Your Attention Please: Treating ADHD
CME/CE credits: 2.5  |   October 8, 2022  |   Free Virtual Event

Image

NEI Psychopharm Channel
Amphetamine Vs. Methylphenidate
Learn how amphetamine and methylphenidate act differently on the brain to produce stimulant effects.

Image

Encore Presentation
ADHD, Female Hormones, and Menopause: The Little We Know From the Research
CME/CE Credit: 1.0 | Expires: April 24, 2025

Image

Encore Presentation
Throughout the Lifespan: Optimizing Treatment for ADHD
CME/CE credits: 0.75  |  Expires: April 24, 2025

Image

This Month in Psychopharmacology
FDA Approves Nonstimulant Option For Adults With ADHD
April 29, 2022